New Medications for Substance Use Disorders: Challenges and Opportunities

被引：0
|
作者：
Nora D Volkow
Phil Skolnick
机构：
[1] National Institute on Drug Abuse,
来源：
Neuropsychopharmacology | 2012年 / 37卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
An increased understanding of the biological mechanisms underlying the process of addiction has led to unique molecular targets and strategies for pharmacotherapies against addiction. However, the successful translation of these discoveries will require: 1) a more active engagement of the pharmaceutical sector, 2) partnership with regulatory agencies to arrive at meaningful outcomes for medication approval and 3) a greater involvement of the healthcare system in the screening and treatment of substance use disorders.
引用
收藏
页码：290 / 292
页数：2
相关论文
共 50 条
  • [31] Screening and brief intervention for substance use disorders in times of COVID-19: potential opportunities, adaptations, and challenges
    Ghosh, Abhishek
    Sharma, Kshitiz
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2021, 47 (02): : 154 - 159
  • [32] Challenges in genetic studies of the etiology of substance use and substance use disorders: Introduction to the special issue
    Prescott, Carol A.
    Madden, Pamela A. F.
    Stallings, Michael C.
    BEHAVIOR GENETICS, 2006, 36 (04) : 473 - 482
  • [33] Challenges in Genetic Studies of the Etiology of Substance Use and Substance Use Disorders: Introduction to the Special Issue
    Carol A. Prescott
    Pamela A.F. Madden
    Michael C. Stallings
    Behavior Genetics, 2006, 36 : 473 - 482
  • [34] The treatment of venous thromboembollic disorders: new challenges and opportunities
    Prandoni, P
    HAEMATOLOGICA, 2003, 88 (06) : 610 - 613
  • [35] New pharmacotherapies for genetic neuromuscular disorders: opportunities and challenges
    Ricci, Federica
    Vacchetti, Martina
    Brusa, Chiara
    Vercelli, Liliana
    Davico, Chiara
    Vitiello, Benedetto
    Mongini, Tiziana
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (08) : 757 - 770
  • [36] New glutamatergic target for alcohol and substance use disorder medications
    Csaba Vadasz
    Mariko Saito
    Psychopharmacology, 2014, 231 : 1429 - 1431
  • [37] Perceptions of the State Policy Environment and Adoption of Medications in the Treatment of Substance Use Disorders
    Knudsen, Hannah K.
    Abraham, Amanda J.
    PSYCHIATRIC SERVICES, 2012, 63 (01) : 19 - 25
  • [38] New glutamatergic target for alcohol and substance use disorder medications
    Vadasz, Csaba
    Saito, Mariko
    PSYCHOPHARMACOLOGY, 2014, 231 (07) : 1429 - 1431
  • [39] Quality Measures For Mental Health And Substance Use: Gaps, Opportunities, And Challenges
    Pincus, Harold Alan
    Scholle, Sarah Hudson
    Spaeth-Rublee, Brigitta
    Hepner, Kimberly A.
    Brown, Jonathan
    HEALTH AFFAIRS, 2016, 35 (06) : 1000 - 1008
  • [40] Adolescent substance use: Challenges and opportunities related to COVID-19
    Sarvey, Dana
    Welsh, Justine W.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 122
12345